GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ABL Bio Inc (XKRX:298380) » Definitions » Change In Other Working Capital

ABL Bio (XKRX:298380) Change In Other Working Capital : ₩-34,279 Mil (TTM As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is ABL Bio Change In Other Working Capital?

ABL Bio's Change In Other Working Capital for the quarter that ended in Jun. 2024 was ₩-8,945 Mil. It means ABL Bio's Other Working Capital declined by ₩8,945 Mil from Mar. 2024 to Jun. 2024 .

ABL Bio's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was ₩-32,679 Mil. It means ABL Bio's Other Working Capital declined by ₩32,679 Mil from Dec. 2022 to Dec. 2023 .

ABL Bio Change In Other Working Capital Historical Data

The historical data trend for ABL Bio's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABL Bio Change In Other Working Capital Chart

ABL Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Other Working Capital
Get a 7-Day Free Trial -3,873.38 -2,259.23 250.47 60,780.00 -32,678.91

ABL Bio Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6,496.03 -9,076.22 -8,477.79 -7,780.66 -8,944.67

ABL Bio Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-34,279 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ABL Bio Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of ABL Bio's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

ABL Bio Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ABL Bio Inc (XKRX:298380) » Definitions » Change In Other Working Capital
Comparable Companies
XKRX:064550 XKRX:016790 XKRX:085660 XKRX:096530 XKRX:005250 XKRX:950160 XKRX:950210 XKRX:087010 XKRX:141080 XKRX:310210 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
2nd Floor, 16 Daewangpangyo-Ro 712, Beon-Gil, Bundang-Gu, Gyeonggi-do, Seongnam-si, KOR, 13488
Website
https://www.ablbio.com
ABL Bio Inc is a Korean biotech research company. The company is engaged in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline products include ABL001 an Bispecific Antibody, ABL201-205 an Antibody Drug Conjugate, T cell engager, Dual Immune Cell Targeting BsAb an Immuno-Oncology, ABL301 an BBB-Penetrating Bispecific Antibody.

ABL Bio Headlines

No Headlines